Research Store

Research Store

Research Store
add to cart Register yourself and then log-in with your user ID and password, before clicking on 'Add to Cart'
Issue Date:26 September 2015     Price in Rs. R 6000    Price in USD. $ 100

Biological E Limited, a company established as far back as 1953, has only recently burst into prominence. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, Pan American Health Organisations, other global markets and within India to Central and State Government Hospitals, Public Sector Undertakings, the Indian Armed Forces and the domestic retail market.

Riding on stellar growth performance over FY13 and FY14, it has suddenly emerge as a robust highly profitable company. In FY14, BE reported an EBITDA margin of 51%, and a net margin of 34%.

It makes several important vaccines like Pentavalent, which has emerged as a major growth driver. BE has inked several important strategic deals in recent years with leading global pharma companies, allowing robust growth in exports.

  • Company Background
  • Business Highlights
  • Technology
  • Future Plans
  • Finacial Performance


  • Board of Directors
  • Financial Summary
  • Profit & Loss Account
  • Balance Sheet
  • Ratios


Biological E Limited